Acamprosate Calcium/Baclofen

阿坎酸钙/巴氯芬

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAcamprosate Calcium/Baclofen
Drug Alias NameBaclofen/Acamprosate阿坎酸钙+巴氯芬Baclofen and Acamprosate Calcium巴氯芬+阿坎酸钙Acamprosate Calcium and Baclofen +[11] 
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptorGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsYes BaclofenAcamprosate Calcium
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharnext SaUniversity of BordeauxInserm +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharnext Sa
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A